Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
暂无分享,去创建一个
James E. Cox | Mark D. Erion | Jared Rutter | Margaret S. Wu | Heather Zhou | David E. Kelley | Ying Qian | Doris Hissako Sumida | Aleksandr Petrov | William L. Holland | M. Erion | J. Rutter | G. Lancaster | D. H. Sumida | S. Summers | D. Kelley | D. McLaren | S. Previs | A. Howard | Aleksandr Petrov | W. Holland | Liping Wang | Bhagirath Chaurasia | Liangsu Wang | Margaret Wu | Mackenzie Pearson | M. Siddique | Ying Li | Xiaolan Shen | Ying Chen | Xiaolan Shen | Bhagirath Chaurasia | Trevor S. Tippetts | Rafael Mayoral Monibas | Jinqi Liu | Ying Li | Liping Wang | Joseph L. Wilkerson | C. Rufus Sweeney | Renato Felipe Pereira | J. Alan Maschek | Vincent Kaddai | Graeme Iain Lancaster | Monowarul Mobin Siddique | Annelise Poss | Mackenzie Pearson | Santhosh Satapati | David G. McLaren | Stephen F. Previs | Ying Chen | Jun Yao | Christian N. Nunes | Andrew D. Howard | Liangsu Wang | Scott A. Summers | R. F. Pereira | Heather H. Zhou | Jun Yao | Jinqi Liu | C. N. Nunes | S. Satapati | J. Cox | Y. Qian | J. A. Maschek | T. Tippetts | V. Kaddai | Annelise M. Poss | Rafael Mayoral Monibas | R. Mayoral Monibas | C. R. Sweeney | M. M. Siddique | C. Nunes | M. Pearson | S. Summers | J. Maschek
[1] L. Sandirasegarane,et al. Ceramide-induced Inhibition of Akt Is Mediated through Protein Kinase Cζ , 2002, The Journal of Biological Chemistry.
[2] M. Birnbaum,et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. , 2007, Cell metabolism.
[3] S. Summers,et al. Does This Schlank Make Me Look Fat? , 2018, Trends in Endocrinology & Metabolism.
[4] Scott D Covey,et al. Cholesterol depletion inhibits fatty acid uptake without affecting CD36 or caveolin-1 distribution in adipocytes. , 2007, Biochemical and biophysical research communications.
[5] S. Summers,et al. Ceramides – Lipotoxic Inducers of Metabolic Disorders , 2015, Trends in Endocrinology & Metabolism.
[6] F. Liu,et al. Regulation of Insulin Action by Ceramide , 2004, Journal of Biological Chemistry.
[7] P. Meikle,et al. Adipocyte Ceramides Regulate Subcutaneous Adipose Browning, Inflammation, and Metabolism. , 2016, Cell metabolism.
[8] L. Almasy,et al. PLASMA DIHYDROCERAMIDE SPECIES ASSOCIATE WITH WAIST CIRCUMFERENCE IN MEXICAN AMERICAN FAMILIES , 2013, Obesity.
[9] J. Hamilton,et al. Fatty acid transport and metabolism in HepG2 cells. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[10] U. Klein,et al. Transcriptional control of adipose lipid handling by IRF4. , 2011, Cell metabolism.
[11] J. Hamilton,et al. Fatty acids are rapidly delivered to and extracted from membranes by methyl-β-cyclodextrin , 2010, Journal of Lipid Research.
[12] S. Summers,et al. Ceramides as modulators of cellular and whole-body metabolism. , 2011, The Journal of clinical investigation.
[13] P. Ferré,et al. Plasma Membrane Subdomain Compartmentalization Contributes to Distinct Mechanisms of Ceramide Action on Insulin Signaling , 2009, Diabetes.
[14] S. Summers,et al. Dihydroceramides: From Bit Players to Lead Actors* , 2015, The Journal of Biological Chemistry.
[15] N. Dimopoulos,et al. Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide. , 2008, The Biochemical journal.
[16] J. Goldstein,et al. Selective versus total insulin resistance: a pathogenic paradox. , 2008, Cell metabolism.
[17] Rebecca A. Johnson,et al. Fatty acid transport , 2001, Journal of Molecular Neuroscience.
[18] C. Kahn,et al. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta. , 2006, Cell metabolism.
[19] V. Salomaa,et al. Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[20] B. Bergman,et al. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans. , 2015, American journal of physiology. Endocrinology and metabolism.
[21] Rhoderick E. Brown,et al. The 4,5-double bond of ceramide regulates its dipole potential, elastic properties, and packing behavior. , 2004, Biophysical journal.
[22] D. Siscovick,et al. Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study , 2018, Diabetes.
[23] I. Albert,et al. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. , 2015, The Journal of clinical investigation.
[24] Yechezkel Barenholz,et al. Sphingomyelin and cholesterol: from membrane biophysics and rafts to potential medical applications. , 2004, Sub-cellular biochemistry.
[25] M. Erion,et al. Quantifying rates of glucose production in vivo following an intraperitoneal tracer bolus. , 2016, American journal of physiology. Endocrinology and metabolism.
[26] D. Accili,et al. Adipocyte SIRT1 knockout promotes PPARγ activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity , 2015, Molecular metabolism.
[27] Adam Kowalczyk,et al. Plasma Lipid Profiling Shows Similar Associations with Prediabetes and Type 2 Diabetes , 2013, PloS one.
[28] R. Bauer,et al. Ceramide Synthase Schlank Is a Transcriptional Regulator Adapting Gene Expression to Energy Requirements. , 2018, Cell reports.
[29] Paul Verkade,et al. Long-chain fatty acid uptake into adipocytes depends on lipid raft function. , 2004, Biochemistry.
[30] Honglin Zhou,et al. Regulation of Insulin-Stimulated Glucose Transporter GLUT4 Translocation and Akt Kinase Activity by Ceramide , 1998, Molecular and Cellular Biology.
[31] Marju Orho-Melander,et al. Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars , 2018, Diabetes Care.
[32] Kim Ekroos,et al. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol , 2016, European heart journal.
[33] M. Orešič,et al. Ceramides Dissociate Steatosis and Insulin Resistance in the Human Liver in Non-Alcoholic Fatty Liver Disease Short title : Ceramides in Human Non-Alcoholic Fatty Liver Disease , 2016 .
[34] J. McDonald,et al. Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis. , 2015, Cell metabolism.
[35] S. Summers,et al. Could Ceramides Become the New Cholesterol? , 2018, Cell metabolism.
[36] J. Hamilton,et al. Fast Diffusion of Very Long Chain Saturated Fatty Acids across a Bilayer Membrane and Their Rapid Extraction by Cyclodextrins , 2009, The Journal of Biological Chemistry.
[37] R. Bishop,et al. Molecular mechanism for lateral lipid diffusion between the outer membrane external leaflet and a beta-barrel hydrocarbon ruler. , 2009, Biochemistry.
[38] A. Suzuki,et al. DES2 protein is responsible for phytoceramide biosynthesis in the mouse small intestine. , 2004, The Biochemical journal.
[39] J. Hamilton,et al. The enigmatic membrane fatty acid transporter CD36: New insights into fatty acid binding and their effects on uptake of oxidized LDL. , 2016, Prostaglandins, leukotrienes, and essential fatty acids.
[40] Ioannis Xenarios,et al. Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans. , 2017, Cell reports.
[41] T. Vogt,et al. AAV8-Mediated Long-Term Expression of Human LCAT Significantly Improves Lipid Profiles in hCETP;Ldlr+/− Mice , 2011, Journal of cardiovascular translational research.
[42] P. Serruys,et al. Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients[S] , 2018, Journal of Lipid Research.
[43] W. Stremmel,et al. Uptake of long chain fatty acids is regulated by dynamic interaction of FAT/CD36 with cholesterol/sphingolipid enriched microdomains (lipid rafts) , 2008, BMC Cell Biology.
[44] J. Hamilton,et al. CD36 enhances fatty acid uptake by increasing the rate of intracellular esterification but not transport across the plasma membrane. , 2013, Biochemistry.
[45] J. Brozinick,et al. Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet , 2012, International Journal of Obesity.
[46] É. Hajduch,et al. Ceramide Disables 3-Phosphoinositide Binding to the Pleckstrin Homology Domain of Protein Kinase B (PKB)/Akt by a PKCζ-Dependent Mechanism , 2003, Molecular and Cellular Biology.